Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human keratinocytes catabolize thymidine.

P M Schwartz1, L C Kugelman, Y Coifman

  • 1Department of Dermatology, Veterans Administration Medical Center, West Haven, Connecticut 06516.

The Journal of Investigative Dermatology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic spectrum of autosomal recessive congenital ichthyosis due to PNPLA1 mutation.

The British journal of dermatology·2017
Same author

The molecular genetic analysis of the expanding pachyonychia congenita case collection.

The British journal of dermatology·2014
Same author

Particle-mediated gene delivery and human skin: ultrastructural observations on stratum corneum barrier structures.

Skin pharmacology and physiology·2007
Same author

Privacy and the economics of personal health care information.

Texas law review·2002
Same author

Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16.

The British journal of dermatology·2001
Same author

Photodegraded nifedipine stimulates uptake and retention of iron in human epidermal keratinocytes.

The Journal of investigative dermatology·2001

Human keratinocytes rapidly break down thymidine, affecting DNA incorporation studies. Continuous thymidine addition is needed for accurate in vitro proliferation measurements.

Area of Science:

  • Dermatology
  • Cell Biology
  • Biochemistry

Background:

  • Human neonatal foreskin keratinocytes proliferate in vitro and incorporate exogenous thymidine into DNA.
  • Keratinocytes' ability to catabolize thymidine has not been previously reported.
  • Thymidine catabolism varies significantly between different tissues and species.

Purpose of the Study:

  • To investigate the catabolism of thymidine by human keratinocytes.
  • To determine the implications of thymidine catabolism for in vitro proliferation studies.
  • To explore the potential impact on thymidine analog therapies for skin diseases.

Main Methods:

  • Cultured human neonatal foreskin keratinocytes were used to study thymidine incorporation and catabolism.
  • Stratified keratinocyte cultures were assessed for their ability to reduce thymidine levels in the medium.

Related Experiment Videos

  • Soluble extracts from various human and animal skin tissues, fibroblasts, and melanocytes were analyzed for thymidine catabolic activity.

    • Main Results:

    • Human keratinocytes, including those from neonatal foreskin and adult skin, actively catabolize thymidine.
    • Stratified keratinocyte cultures reduced medium thymidine by over 90% within 2-4 hours.
    • Linear incorporation of thymidine into DNA was observed for only 2 hours without continuous replenishment, necessitating ongoing addition of radioactive thymidine for extended studies.
    • Skin extracts from mice, rabbits, and guinea pigs showed no thymidine catabolism, unlike human skin.
    • Cultivated human fibroblasts and melanocytes exhibited minimal to no thymidine catabolic activity.

    Conclusions:

    • Keratinocytes possess a significant capacity to catabolize thymidine, impacting [3H]thymidine incorporation assays.
    • Accurate assessment of keratinocyte proliferation in vitro requires strategies to overcome rapid thymidine degradation, such as continuous thymidine addition.
    • Understanding thymidine catabolism in keratinocytes is crucial for the development and application of thymidine analog therapies for cutaneous conditions.